Persistence: 143.6 days (Trulicity) versus 129.9 days (semaglutide). Treatment discontinuation: 30.8 percent (Trulicity) versus 40.8 percent (
TRULICITY. If a hypersensitivity reaction occurs, discontinue TRULICITY; treat promptly per standard of care, and monitor until signs and
A higher percentage of patients who received TRULICITY 0.75 mg (1.3%) and TRULICITY 1.5 mg (3.5%) discontinued Instruct patients to discontinue TRULICITY
Trulicity 1.5 mg and Trulicity 0.75 mg compared to metformin at 26 weeks. (See discontinued their prestudy insulin regimen and were randomised to
Persistence: 143.6 days (Trulicity) versus 129.9 days (semaglutide). Treatment discontinuation: 30.8 percent (Trulicity) versus 40.8 percent (
agonist and insulin, particularly after rapid discontinuation or reduction of concomitant insulin. analogue to Trulicity then start Trulicity a week
If pancreatitis is suspected, promptly discontinue TRULICITY. If pancreatitis is confirmed, TRULICITY should not be restarted.
If pancreatitis is suspected, promptly discontinue TRULICITY. If pancreatitis is confirmed. TRULICITY should not be restarted. TRULICITY has not been
A decision should be made whether to discontinue nursing or to discontinue Trulicity taking into account the importance of the drug to the
Comments